Literature DB >> 3541642

Influence of minor thermal injury on expression of complement receptor CR3 on human neutrophils.

R D Nelson, S R Hasslen, D H Ahrenholz, E Haus, L D Solem.   

Abstract

Thermal injury is well known to inhibit functions of the circulating neutrophil related to its role in host defense against infection, but the mechanism(s) of this phenomenon are not fully understood. To gain further clues to these mechanisms, the authors have studied patients with thermal injury in terms of altered expression of neutrophil cell membrane receptors for the opsonic complement-derived ligand C3bi--complement receptor Type 3, or CR3. CR3 expression was selected for study because an increase in the number of receptors on the cell surface can be stimulated by products of complement activation known to accumulate after thermal injury and because of the role of CR3 in phagocytic and adherence functions of the neutrophil. Expression of CR3 was monitored semiquantitatively by flow cytometry with the use of a murine monoclonal antibody (OKM1) specific for an antigen (CD11) associated with this receptor. Patients evaluated were limited in this study to those with minor degrees of thermal injury (second-degree burn involving less than 20% of total body surface area) so that possible confounding effects of major injury and its complications could be eliminated. It was observed that patient neutrophil CR3 becomes significantly up-regulated during the first week, as early as 1 day after injury. The maximum level of expression of CR3 averaged greater than 150% (range, 70-314%) of the respective minimum level observed for each patient. The minimum levels of expression of CR3 on patient neutrophils, reached 11-37 days after injury for 7 of 8 patients, were comparable to the level of expression of CR3 on unstimulated control neutrophils. Such temporal up-regulation of patient neutrophil CR3 suggests the early generation of stimuli of CR3 mobilization in response to thermal injury. Increased numbers of CR3 on patient neutrophils may augment microbicidal function and enhance or inhibit delivery of cells to the burn site.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3541642      PMCID: PMC1888466     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  16 in total

1.  Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.

Authors:  D P Vik; D T Fearon
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

2.  Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis.

Authors:  M A Arnaout; R M Hakim; R F Todd; N Dana; H R Colten
Journal:  N Engl J Med       Date:  1985-02-21       Impact factor: 91.245

3.  Regulation of neutrophil migratory function in burn injury by complement activation products.

Authors:  J S Solomkin; R D Nelson; D E Chenoweth; L D Solem; R L Simmons
Journal:  Ann Surg       Date:  1984-12       Impact factor: 12.969

4.  Subcellular localization of the large subunit of Mo1 (Mo1 alpha; formerly gp 110), a surface glycoprotein associated with neutrophil adhesion.

Authors:  R F Todd; M A Arnaout; R E Rosin; C A Crowley; W A Peters; B M Babior
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

5.  The distribution of the CR3 receptor on human cells and tissue as revealed by a monoclonal antibody.

Authors:  A Eddy; S L Newman; F Cosio; T LeBien; A Michael
Journal:  Clin Immunol Immunopathol       Date:  1984-06

6.  Deficiency of a surface membrane glycoprotein (Mo1) in man.

Authors:  N Dana; R F Todd; J Pitt; T A Springer; M A Arnaout
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

7.  Human neutrophils increase expression of C3bi as well as C3b receptors upon activation.

Authors:  M Berger; J O'Shea; A S Cross; T M Folks; T M Chused; E J Brown; M M Frank
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

8.  Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.

Authors:  G D Ross; S L Newman; J D Lambris; J E Devery-Pocius; J A Cain; P J Lachmann
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

9.  Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.

Authors:  D I Beller; T A Springer; R D Schreiber
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

10.  A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule.

Authors:  F Sanchez-Madrid; J A Nagy; E Robbins; P Simon; T A Springer
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

View more
  4 in total

1.  Leucocyte integrin and CR1 expression on peripheral blood leucocytes of patients with rheumatoid arthritis.

Authors:  D McCarthy; M J Taylor; J Bernhagen; J D Perry; A S Hamblin
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

Review 2.  The role of neutrophils in vascular injury: a summary of signal transduction mechanisms in cell/cell interactions.

Authors:  G Weissmann
Journal:  Springer Semin Immunopathol       Date:  1989

3.  Role of chemotactic factors in neutrophil activation after thermal injury in rats.

Authors:  M T Piccolo; Y Wang; S Verbrugge; R L Warner; P Sannomiya; N S Piccolo; M S Piccolo; T E Hugli; P A Ward; G O Till
Journal:  Inflammation       Date:  1999-08       Impact factor: 4.092

4.  Increased expression of the interleukin 1 receptor on blood neutrophils of humans with the sepsis syndrome.

Authors:  M B Fasano; S Cousart; S Neal; C E McCall
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.